: This technology is primarily aimed at kidney failure treatment , providing a potential alternative or supplement to traditional dialysis by reducing toxin buildup in the blood.
Hirai's primary research involves , a biocompatible material used to create "oral absorbents". These gels are designed to selectively filter substances in the gastrointestinal tract to help manage uremic toxins. aya hirai
: Creating systems that release medication at specific sites in the body. : This technology is primarily aimed at kidney
: Her most recent publications, including works in the journal Gels (2024) , demonstrate significant improvements in the adsorption capacity of these gels through optimized preparation methods, such as switching from calcium alginate to agar nuclei. Advancing Biomedical Materials aya hirai